Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells

被引:26
|
作者
Mu, D.
Chen, W.
Yu, B.
Zhang, C.
Zhang, Y.
Qi, H.
机构
[1] Fourth Mil Med Univ, Xijing Hosp, Dept Resp Dis, Xian 710032, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Resp Dis, Xian 710032, Peoples R China
关键词
apoptosis; caspase-4; dihydroartemisinin; intracellular calcium concentration; SPC-A-1; cell; survivin;
D O I
10.1358/mf.2007.29.1.1063493
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dihydroartemisinin (DHA), a semisynthetic derivative of artemisinin isolated from the traditional Chinese herb Artemisia annua. is an effective novel antimalarial drug. Recent studies suggest that it also has anticancer effects. The present study investigated the apoptosis activity of DHA in cultured human lung cancer cells by terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay and flow cytometry. Intracellular free calcium concentrations in the lung cancer cells were evaluated by laser scanning confocal microscopy using Fura-3/AM as probe. The observations also indicated that DHA downregulated the mRNA and protein expression level of survivin in the lung cancer cell line SPC-A-1 cells, whereas it did not affect those of caspase-4. These results demonstrated that DHA can induce apoptosis of lung cancer cell line SPC-A-1 cells and that calcium and survivin participated in the apoptotic signalling pathways. (c) 2007 Prous Science. All rights reserved.
引用
收藏
页码:33 / 38
页数:6
相关论文
共 50 条
  • [31] Induction of Apoptosis by Deinoxanthin in Human Cancer Cells
    Choi, Yong-Ji
    Hur, Jung-Mu
    Lim, Sangyong
    Jo, Minho
    Kim, Dong Ho
    Choi, Jong-Il
    ANTICANCER RESEARCH, 2014, 34 (04) : 1829 - 1835
  • [32] PREPARATION OF CISPLATIN COMPOSITE MICRO/NANOFIBERS AND ANTITUMOR ACTIVITY IN VITRO AGAINST HUMAN TUMOR spc-a-1 CELLS
    Chen, Ping
    Wu, Qing-Sheng
    Ding, Ya-Ping
    Zhu, Zi-Chun
    NANO, 2011, 6 (04) : 325 - 332
  • [33] INHIBITION OF GROWTH AND INDUCTION OF APOPTOSIS IN HUMAN LUNG CANCER CELLS BY BR-OXPH
    Koleva, Vanya
    Dragoeva, Asya
    Draganov, Marian
    Melendez-Alafort, Laura
    Rosato, Antonio
    Uzunov, Nikolay
    Enchev, Dobromir
    GENETIKA-BELGRADE, 2014, 46 (01): : 1 - 10
  • [34] siRNA-induced TRAF6 knockdown promotes the apoptosis and inhibits the invasion of human lung cancer SPC-A1 cells
    He, Zhiyong
    Huang, Chuanzhong
    Lin, Gen
    Ye, Yunbin
    ONCOLOGY REPORTS, 2016, 35 (04) : 1933 - 1940
  • [35] Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells
    Ying-Ying Lu
    Tong-Sheng Chen
    Jun-Le Qu
    Wen-Liang Pan
    Lei Sun
    Xun-Bin Wei
    Journal of Biomedical Science, 16
  • [36] Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells
    Lu, Ying-Ying
    Chen, Tong-Sheng
    Qu, Jun-Le
    Pan, Wen-Liang
    Sun, Lei
    Wei, Xun-Bin
    JOURNAL OF BIOMEDICAL SCIENCE, 2009, 16
  • [37] Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis
    Hongyu Chen
    Shiyan Gu
    Huangmei Dai
    Xinyang Li
    Zunzhen Zhang
    Biological Trace Element Research, 2017, 179 : 203 - 212
  • [38] Bax translocation into mitochondria during dihydroartemisinin(DHA)-induced apoptosis in human lung adenocarcinoma cells
    Lu, Ying-ying
    Chen, Tong-sheng
    Qu, Jun-Le
    BIOPHOTONICS AND IMMUNE RESPONSES IV, 2009, 7178
  • [39] Dihydroartemisinin Sensitizes Human Lung Adenocarcinoma A549 Cells to Arsenic Trioxide via Apoptosis
    Chen, Hongyu
    Gu, Shiyan
    Dai, Huangmei
    Li, Xinyang
    Zhang, Zunzhen
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2017, 179 (02) : 203 - 212
  • [40] Dihydroartemisinin and cisplatinum synergistically induced apoptosis in human lung adenocarcinoma H1299 cells
    Yin, Xiaobo
    Wang, Ping
    Xu, Shufeng
    Tian, Qi
    Zheng, Yue
    Li, Aiming
    Zhao, Jing
    Liu, Feifei
    Gao, Liming
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (03): : 1772 - 1783